Top 5 Most Read RNS's on Vox Markets for Wednesday 21st September 2022
Episode 907, Sep 21, 2022, 06:46 AM
Top 5 Most Read RNS's on Vox Markets for Wednesday 21st September 2022
5. Blue Star Capital #BLU - Holding(s) in Company
Mark White's holdings have reduced from 10.7% to 8.3%.
4. Dev Clever Holdings #DEV - Launch of Career Success Membership Program
Dev Clever will be exhibiting at DIDAC, Asia's largest education conference and exhibition held at Bangalore, India where it will unveil further progress on its Launchmycareer platform with the launch of its Career Success Membership Program.
3. Greatland Gold #GGP - Notice of General Meeting
A General Meeting will be held at Salisbury House, London Wall IN London on Friday, 7th October 2022 at 9.30am.
2. EQTEC #EQT - Southport Project Ownership Update
The Company has executed with Rotunda Group and certain of its subsidiaries a series of legal agreements to accelerate development of the Southport Hybrid Energy Park.
1. Poolbeg Pharma POLB - Poolbeg licence of Melioidosis vaccine candidate
Poolbeg Pharma has signed an exclusive Licence Agreement with University College Dublin (UCD) for a late preclinical stage vaccine candidate for Melioidosis, a disease for which there is no current approved vaccine available.
5. Blue Star Capital #BLU - Holding(s) in Company
Mark White's holdings have reduced from 10.7% to 8.3%.
4. Dev Clever Holdings #DEV - Launch of Career Success Membership Program
Dev Clever will be exhibiting at DIDAC, Asia's largest education conference and exhibition held at Bangalore, India where it will unveil further progress on its Launchmycareer platform with the launch of its Career Success Membership Program.
3. Greatland Gold #GGP - Notice of General Meeting
A General Meeting will be held at Salisbury House, London Wall IN London on Friday, 7th October 2022 at 9.30am.
2. EQTEC #EQT - Southport Project Ownership Update
The Company has executed with Rotunda Group and certain of its subsidiaries a series of legal agreements to accelerate development of the Southport Hybrid Energy Park.
1. Poolbeg Pharma POLB - Poolbeg licence of Melioidosis vaccine candidate
Poolbeg Pharma has signed an exclusive Licence Agreement with University College Dublin (UCD) for a late preclinical stage vaccine candidate for Melioidosis, a disease for which there is no current approved vaccine available.